Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2006-09-05
2006-09-05
Channavajjala, Lakshmi (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S456000, C424S459000, C424S462000
Reexamination Certificate
active
07101574
ABSTRACT:
The invention concerns a pharmaceutical composition containing micronized fenofibrate, a surfactant and a binding cellulose derivative, as solubilizing adjuvant, preferably hydroxypropylmethylcellulose. The cellulose derivative represents less than 20 wt. % of the composition. The association of micronized fenofibrate with a binding cellulose derivative, as solubilizing adjuvant and a surfactant enables enhanced bioavailability of the active principle. The invention also concerns a method for preparing said composition without using any organic solvent.
REFERENCES:
patent: 3914286 (1975-10-01), Mieville
patent: 4058552 (1977-11-01), Mieville
patent: 4412986 (1983-11-01), Kawata et al.
patent: 4717569 (1988-01-01), Harrison et al.
patent: 4752470 (1988-06-01), Mehta
patent: 4800079 (1989-01-01), Boyer
patent: 4895726 (1990-01-01), Curtet
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5545628 (1996-08-01), Deboeck et al.
patent: 5776495 (1998-07-01), Duclos et al.
patent: 5840330 (1998-11-01), Stemmle et al.
patent: 6074670 (2000-06-01), Stamm et al.
patent: 6277405 (2001-08-01), Stamm et al.
patent: 2004/0137055 (2004-07-01), Criere et al.
patent: 012523 (1980-06-01), None
patent: 0164 959 (1985-12-01), None
patent: 0 330 532 (1989-08-01), None
patent: 0 514 967 (1992-11-01), None
patent: 0 519 144 (1992-12-01), None
patent: 793 958 (1997-09-01), None
patent: 219 341 (1997-03-01), None
patent: WO 82/01649 (1982-05-01), None
patent: WO 98/31360 (1988-07-01), None
patent: WO 96/01621 (1996-01-01), None
patent: WO 98/00116 (1998-01-01), None
patent: WO 98/31361 (1998-07-01), None
The Merck Index- An encyclopedia of chemicals, drugs and biologicals. Twefth edition. 1996, p. 3260.
A. Munoz et al., “Micronised Fenofibrate”,Atherosclerosis110 (Suppl.) (1994) S45-S48, Elsevier Science, Ireland.
D.F. Temeljotov et al., “Solubilization and Dissolution Enhancement for Sparingly Soluble Fenofibrate”,Acta. Pharm.46 (1996) 131-136.
I. Ghebre-Sellassie “Pellets: A General Overview”,Pharmaceutical Pelletization Technology, Drugs and the Pharmaceutical Sciences, 37, pp. 2, 3, 234, edited by Isaac Ghebre-Sellassie, Marcel Dekker, Inc. NY NY.
R. Bianchini et al., “Influence of Drug Loading on Coated Beads Release Using Air Suspension Technique”,Boll. Chim. Farmaceutico, 128 Dec. 12, 1989, pp. 373-379.
Dr. Bernhard Luy, “Methods of Pellet Production”, Presented at Glatt Symposium, Strasbourg, Oct. 1992, pp. 1-12, with curriculum vitae.
A. Kuchiki et al., “Stable Solid Dispersion System Against Humidity”,Yakuzaigaku44(1) 31-37 (1984) pp. 1-13.
JP Guichard et al., “A New Formulation of Fenofibrate: Suprabioavailable Tablets”, Current Medical Research and Opinion 16(2) (2000) pp. 134-138, Laboratoires Fournier, France.
Chenevier Philippe
Criere Bruno
Suplie Pascal
Buchanan & Ingersoll & Rooney PC
Channavajjala Lakshmi
Laboratoires des Produits Ethiques Ethypharm
LandOfFree
Pharmaceutical composition containing fenofibrate and the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition containing fenofibrate and the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing fenofibrate and the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3604943